Saturday, July 19, 2025
  • Login
Forbes 40under40
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle
No Result
View All Result
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle
No Result
View All Result
Forbes 40under40
No Result
View All Result
Home Lifestyle

Philips’ second-biggest investor raises stake after apnoea deal

by Mark Darwin
in Lifestyle
Philips’ second-biggest investor raises stake after apnoea deal
Share on FacebookShare on Twitter


This comes after Exor, its largest shareholder, increased shareholding in the company to 17.5% from 16.1%

A SECOND major Philips investor raised its holding in the medical technology giant, two months after the Dutch company settled claims linked to its faulty sleep apnoea machines.  

Artisan Partners raised its stake in Philips to 10 per cent by Jun 28, reported a filing with the Dutch Authority for the Financial Markets (AFM) on Wednesday (Jul 3).

The holding cements Artisan’s position as Philips’ second-largest shareholder after Agnelli-controlled Exor.

“Artisan has owned more than 9 per cent in Philips for quite some time, and have recently increased their stake to 10 per cent after first-quarter results,” Philips spokesperson Steve Heywood said. 

Wisconsin-based Artisan Partners did not respond to an e-mail seeking comment outside of business hours.

The announcement comes on the heels of Exor boosting its stake in Philips to 17.5 per cent from 16.1 per cent. The Dutch company is regaining the confidence of some investors after a lower-than-expected settlement on US claims linked to faulty sleep apnoea devices in late April. 

BT in your inbox

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

The recall – related to the concerns over disintegrating noise-cancelling foam that patients inhaled – cost the company around US$5 billion, Bloomberg calculations showed.

The US Food and Drug Administration has labelled the fault a Class 1 issue, the most serious type. The company is still being investigated by the US Department of Justice, and has not yet made any financial provisions for that matter. 

Shares of Philips have gained around 17 per cent this year, but are still down 44 per cent since it issued the recall in June 2021. BLOOMBERG

Tags: apnoeaDealinvestorPhilipsRaisessecondbiggestStake
Mark Darwin

Mark Darwin

Next Post
Germany launches electric truck charging network

Germany launches electric truck charging network

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.

 
 
 
 

NEWS

  • Forbes Magazine
  • Technology
  • Innovation
  • Money
  • Leadership
  • Real Estate
  • Lifestyle
Instagram Facebook Youtube

© 2024 Forbes 40under40. All Rights Reserved.

  • About Us
  • Advertise
  • Contact Us
No Result
View All Result
  • Home
  • Technology
  • Innovation
  • Real Estate
  • Leadership
  • Money
  • Lifestyle

© 2024 Forbes 40under40. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In